Dr. Ewa Tomczak, MD

Dr. Tomczak practices at John Sealy Hospital in Galveston, Texas, part of The University of Texas System.

Dr. Tomczak's NPI, 1215389648, was assigned on July 11, 2016. Dr. Tomczak graduated from University of Medical Science Poznan in 2012. Dr. Tomczak holds Texas license U8836.

Dr. Tomczak's primary practice is John Sealy Hospital, at 301 University Boulevard, Galveston, TX 77555 in Galveston County. The practice phone is (409) 772-1011.

Dr. Tomczak's primary practice is John Sealy Hospital in Galveston, Texas, part of The University of Texas System. The medical group on file is UTMB Faculty Group Practice.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tomczak practices. Vendor and product names are available with a free account.

Infectious disease is Dr. Tomczak's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Tomczak is board certified in infectious disease by the American Board of Internal Medicine. Dr. Tomczak is licensed in Texas.

CMS data shows 114 Medicare services from Dr. Tomczak across 2 procedure codes in 2024, for 47 Medicare patients. Medicare paid $7,931 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 47 Medicare patients who saw Dr. Tomczak in 2024. The largest group is 75 to 84, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tomczak's median patient age at 67, with 48% women.

In 2024, Dr. Tomczak wrote 12 Medicare Part D claims. They cover 20 drugs, with $19,891 in total drug cost. In 2018, CMS named 1,035 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Tomczak for performance year 2024, reported as part of a group. Dr. Tomczak accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Tomczak, published from 2006 to 2022. The most frequent topics are Lymphoma, Large B-Cell, Diffuse and Signal Transduction. Dr. Tomczak's most frequent co-authors are Adam Bagg, MD, Alison W. Loren, MD and Selina Luger, MD.

CMS Open Payments shows 4 general payments to Dr. Tomczak from 2 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Paratek Pharmaceuticals, Inc. paid the most, $41.

Dr. Tomczak graduated from University of Medical Science Poznan in 2012.

Dr. Tomczak is in network with 21 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.